本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

梯瓦製藥

15.02
+0.15001.01%
盤前15.230.2100+1.40%04:16 EDT
成交量:1,200.58萬
成交額:1.81億
市值:172.27億
市盈率:-10.36
高:15.45
開:15.33
低:14.81
收:14.87
資料載入中...
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/06/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/02/21

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/25

重要事件披露

Current report, items 1.01, 2.03, and 9.01
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 5.02 and 9.01
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/06

持股變動聲明

Statement of changes in beneficial ownership of securities